Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
. 1971 Aug 28;3(5773):508–512. doi: 10.1136/bmj.3.5773.508

Intrathecal Chemotherapy in Burkitt's Lymphoma*

J L Ziegler, A Z Bluming
PMCID: PMC1800463  PMID: 5109411

Abstract

Meningeal involvement with Burkitt lymphoma cells constitutes the most challenging therapeutic problem in the management of Burkitt's tumour. The results of intrathecal chemotherapy with methotrexate or cytosine arabinoside in 55 episodes of malignant pleocytosis in 38 patients with Burkitt's tumour are described. The response was complete in nearly all patients after the administration of either agent. Cerebrospinal fluid (C.S.F.) remissions were more prolonged in patients receiving intrathecal methotrexate or cytosine arabinoside daily for four days as opposed to a 10-day schedule. A controlled randomized trial of “prophylactic” intrathecal chemotherapy in patients without malignant cells in the C.S.F. on admission showed no protective effect against the subsequent development of malignant pleocytosis. Future therapeutic approaches are considered in the light of these results.

Full text

PDF
508

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cooper E. H., Hughes D. T., Topping N. E. Kinetics and chromosome analyses of tissue culture lines derived from Burkitt lymphomata. Br J Cancer. 1966 Mar;20(1):102–113. doi: 10.1038/bjc.1966.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. RIESELBACH R. E., DI CHIRO G., FREIREICH E. J., RALL D. P. Subarachnoid distribution of drugs after lumbar injection. N Engl J Med. 1962 Dec 20;267:1273–1278. doi: 10.1056/NEJM196212202672502. [DOI] [PubMed] [Google Scholar]
  3. RIESELBACH R. E., MORSE E. E., RALL D. P., FREI E., 3rd, FREIREICH E. J. Intrathecal aminopterin therapy of meningeal leukemia. Arch Intern Med. 1963 May;111:620–630. doi: 10.1001/archinte.1963.03620290086011. [DOI] [PubMed] [Google Scholar]
  4. Rall D. P. Conference on obstacles to the control of acute leukemia. Experimental studies of the blood-brain barrier. Cancer Res. 1965 Oct;25(9):1572–1577. [PubMed] [Google Scholar]
  5. Rubin R. C., Ommaya A. K., Henderson E. S., Bering E. A., Rall D. P. Cerebrospinal fluid perfusion for central nervous system neoplasms. Neurology. 1966 Jul;16(7):680–692. doi: 10.1212/wnl.16.7.680. [DOI] [PubMed] [Google Scholar]
  6. Sullivan M. P., Vietti T. J., Fernbach D. J., Griffith K. M., Haddy T. B., Watkins W. L. Clinical investigations in the treatment of meningeal leukemia: radiation therapy regimens vs. conventional intrathecal methotrexate. Blood. 1969 Sep;34(3):301–319. [PubMed] [Google Scholar]
  7. Thomas L. B. Pathology of leukemia in the brain and meninges: postmortem studies of patients with acute leukemia and of mice given inoculations of L1210 leukemia. Cancer Res. 1965 Oct;25(9):1555–1571. [PubMed] [Google Scholar]
  8. Wang J. J., Pratt C. B. Intrathecal arabinosyl cytosine in meningeal leukemia. Cancer. 1970 Mar;25(3):531–534. doi: 10.1002/1097-0142(197003)25:3<531::aid-cncr2820250306>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  9. Yoshida Y. Reticulum cell sarcoma of the breast. Case report and a review of the Japanese literature. Cancer. 1970 Jul;26(1):94–99. doi: 10.1002/1097-0142(197007)26:1<94::aid-cncr2820260111>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  10. Ziegler J. L., Bluming A. Z., Morrow R. H., Fass L., Carbone P. P. Central nervous system involvement in Burkitt's lymphoma. Blood. 1970 Dec;36(6):718–728. [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES